Order results by:
| Issue | Title | |
| Vol 10, No 1 (2018) | Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy | Abstract similar documents |
| N. V. Pizova | ||
| "... The paper gives data on the incidence of cerebrovascular diseases (CVD) and the pathogenetic ..." | ||
| Vol 12, No 5 (2020) | The etiology, manifestations, and therapy of chronic cerebrovascular diseases | Abstract similar documents |
| A. G. Gogoleva, V. V. Zakharov | ||
| "... The paper presents the current etiopathogenetic classification of chronic cerebrovascular diseases ..." | ||
| Vol 4, No 1 (2012) | Current approaches to therapy for chronic forms of cerebrovascular diseases | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, T A Popova, M M Tanashyan | ||
| "... diseases (CVD). The combined treatment of patients with chronic CVD comprises antiaggregants (in patients ..." | ||
| Vol 3, No 1 (2011) | Clinical experience with Neurox used in patients with cerebrovascular disease | Abstract similar documents |
| N. G. Mayorova, V. A. Pavlov | ||
| "... (Neurox) used as a component of combination therapy in 32 patients with cerebrovascular diseases (CVD): 10 ..." | ||
| Vol 15, No 4 (2023) | The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) | Abstract similar documents |
| M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva | ||
| "... precursors. Future research should clarify the role of TMO in the development of cerebrovascular disease (CVD ..." | ||
| Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
| V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
| "... of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating ..." | ||
| Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
| "... of adherence in cerebrovascular disease (CVD), depending on the clinical picture of the disease and comorbid ..." | ||
| Vol 9, No 3 (2017) | Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program | Abstract similar documents |
| G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva | ||
| "... with initial manifestations of chronic cerebrovascular disease (CVD) in outpatient neurological and therapeutic ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... in the treatment of MCI in patients with cerebrovascular disease (CVD) in real clinical practice. Material ..." | ||
| Vol 12, No 5 (2020) | Cognitive function dynamics in comorbid patients after angioreconstructive interventions | Abstract PDF (Eng) similar documents |
| M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, E. S. Berdnikovitch, R. B. Medvedev, I. I. Titkova, A. V. Naminov, A. V. Annushkin | ||
| "... for cerebrovascular diseases (CVD). At the same time, their prognosis in comorbid patients, particularly in those ..." | ||
| Vol 7, No 1 (2015) | Clinical experience with L-lysine escinate for acute and chronic cerebral circulatory disorders | Abstract similar documents |
| N. V. Pizova | ||
| "... Cerebrovascular diseases (CVD) are major causes of disability and death in Russia. Stroke ..." | ||
| Vol 15, No 2 (2023) | Management of patients with chronic cerebrovascular disease | Abstract similar documents |
| Yu. A. Starchina, O. V. Kosivtsova, E. A. Sokolov | ||
| "... Cerebrovascular disease is one of the most common pathologies in the practice of a neurologist ..." | ||
| Vol 7, No 1 (2015) | Cognitive impairments in cerebrovascular disease: What is between health and dementia? | Abstract similar documents |
| A. Yu. Emelin | ||
| "... prevalence of both acute and chronic forms of cerebrovascular diseases (CVD). Cognitive dysfunctions ..." | ||
| Vol 9, No 3 (2017) | Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) | Abstract similar documents |
| N. N. Koberskaya | ||
| "... of Alzheimer's disease (AD) according to the proceeding of the Alzheimer's Association International Conference ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov | ||
| "... up with a diagnosis of CCI, DEP, have no signs of chronic cerebrovascular disease (CVD), but suffer ..." | ||
| Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
| T. G. Voznesenskaya | ||
| "... The paper discusses the topical problem of depression in cerebrovascular diseases. It shows its ..." | ||
| Vol 13, No 1 (2021) | Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (pre-dementia) stage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, A. Yu. Emelin, A. N. Bogolepova, O. B. Doronina, V. V. Zakharov, O. V. Kolokolov, S. V. Kotov, L. L. Korsunskaya, M. A. Kutlubaev, V. B. Laskov, O. S. Levin, V. A. Parfenov | ||
| "... cerebrovascular disease (CVD) (chronic cerebral ischemia (CCI) and dyscirculatory encephalopathy (DEP)) at the pre ..." | ||
| Vol 9, No 2 (2017) | Cerebrovascular disease mortality rates in the population over 50 years of age in Russia and the USA over a 15-year period | Abstract similar documents |
| I. V. Samorodskaya, E. M. Andreev, O. V. Zaratyants, O. V. Kosivtsova, E. P. Kakorina | ||
| "... Objective: to compare standardized mortality ratios (SMRs) from cerebrovascular diseases (CVD ..." | ||
| Vol 6, No 4 (2014) | Cognitive impairments in cerebrovascular disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... Cerebrovascular diseases belong to a group of the major causes of cognitive impairments ..." | ||
| Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... of cerebrovascular disease (CVD). Some non-drug and drug methods can reduce the manifestations of CI, improve ..." | ||
| Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
| A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
| "... The efficacy of naftidrofuryl in treating cerebrovascular diseases is analyzed on the basis ..." | ||
| Vol 6, No 1 (2014) | Cerebral venous disorders: diagnosis, clinical features | Abstract similar documents |
| E. I. Chukanova, A. S. Chukanova, N. D. Daniyalova | ||
| "... of the brain. The etiologic and pathogenetic aspects of CVD, as well as of thromboses of the intracranial veins ..." | ||
| Vol 3, No 2 (2011) | Arterial rigidity and cerebrovascular disorders | Abstract similar documents |
| L. A. Geraskina, A. V. Fonyakin, A. R. Magomedova | ||
| "... and secondary prevention of cerebrovascular diseases involves correction of risk factors, modification ..." | ||
| Vol 11, No 4 (2019) | Mathematical modeling of ischemic stroke | Abstract similar documents |
| V. I. Ershov, A. N. Chirkov, A. P. Gonchar-Zaykin, S. N. Lyashchenko, T. Yu. Lozinskaya, N. V. Gumalatova, G. E. Kuznetsov, L. R. Tenchurina | ||
| "... IS of various locations and pathogenetic subtypes were examined. The impact of plasma osmolarity or sodium ..." | ||
| Vol 2, No 1 (2010) | SUCCINIC ACID DERIVATIVES IN THERAPY FOR CEREBROVASCULAR DISEASE | Abstract similar documents |
| N. V. Pizova | ||
| "... in different forms of cerebrovascular disease. The use of oxidants is stated to be one of the lines of therapy ..." | ||
| Vol 2, No 4 (2010) | Chronic ischemic cerebrovascular diseases: pathogenesis and treatment | Abstract similar documents |
| N. V. Pizova, D. S. Druzhinin | ||
| Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
| D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
| "... Chronic cerebrovascular diseases (CVD) and neurodegenerative diseases (NDD) are the most common ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Alzheimer's disease | Abstract similar documents |
| N. N. Koberskaya | ||
| "... 's disease (AD). It discusses the issues of symptomatic and pathogenetic treatments and combination therapy ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... COVID-19 worsens the course of cerebrovascular diseases (CVD), including chronic cerebral ..." | ||
| Vol 11, No 3 (2019) | Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? | Abstract similar documents |
| G. R. Tabeeva, E. A. Kirjanova | ||
| "... on the clinical manifestation, severity, and rate of progression of CI. Alzheimer's disease (AD) and vascular CI ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... due to cerebrovascular (CVD) and neurodegenerative diseases (NDD) of the brain. Material and methods ..." | ||
| Vol 8, No 3 (2016) | Diagnosis and treatment of chronic cerebrovascular disease, use of pentoxifylline | Abstract PDF (Eng) similar documents |
| V. A. Parfenov | ||
| "... Chronic cerebrovascular disease (CCVD) is one of the most common iagnoses in Russian neurology ..." | ||
| Vol 10, No 1 (2018) | Treatment of vertigo in elderly patients with chronic cerebrovascular disease | Abstract similar documents |
| S. N. Duma | ||
| "... elderly patients (mean age, 73.7 years) with chronic cerebrovascular disease and complaints of dizziness ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... . The most common causes of MCI are Alzheimer’s disease (AD), cerebrovascular disease, or a combination ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
| I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
| "... to the development/progression of many diseases, including cerebrovascular disease and multiple sclerosis. Von ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
| A. N. Bogolepova | ||
| "... Vascular depression is a very frequent and serious complication of cerebrovascular diseases ..." | ||
| Vol 2, No 2 (2010) | Vertebrobasilar insufficiency: clinical and diagnostic aspects | Abstract similar documents |
| S. K. Volkov | ||
| "... The paper presents current methods for the diagnosis and treatment of cerebrovascular diseases ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease ..." | ||
| Vol 13, No 3 (2021) | From accurate diagnosis to targeted therapy: depression in general medical practice | Abstract similar documents |
| N. N. Petrova | ||
| "... suffering from cardiovascular diseases and 35 patients with cerebral small vessel disease. Clinical ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
| Vol 8, No 3 (2016) | Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review | Abstract similar documents |
| A. G. Merkin, V. A. Kazhin, A. N. Komarov, A. V. Fonarev, V. A. Priyatel, I. A. Nikiforov | ||
| "... the burden of diseases and overloads healthcare systems. Therefore prevention strategies are currently ..." | ||
| Vol 15, No 6 (2023) | Comorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin, A. Yu. Efimtsev, S. V. Vorobyov | ||
| "... combination with other nosological forms. CAA is a disease associated with both Alzheimer's type ..." | ||
| Vol 13, No 3 (2021) | Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy | Abstract similar documents |
| I. A. Strokov, V. V. Oganov | ||
| "... trials. The article discusses the possible disease-modifying effect of ALA. ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... with chronic cerebrovascular disease (CCVD) and cognitive impairment (CI). Patients and methods. A total of 67 ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... .3 scores, respectively; p<0.05). Imbalance of angiogenic and antiangiogenic factors can cause disease ..." | ||
| Vol 15, No 6 (2023) | Choline alfoscerate in the correction of cognitive impairment | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova | ||
| "... be recommended both as monotherapy and as part of complex therapy in patients with cerebrovascular diseases ..." | ||
| Vol 1, No 1 (2009) | TENOTEN IN COMPLEX THERAPY FOR CEREBROVASCULAR INSUFFICIENCY IN ELDERLY PATIENTS | Abstract similar documents |
| L. D. Serova | ||
| "... with cerebrovascular diseases. ..." | ||
| Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
| V. N. Shishkova, T. V. Adasheva | ||
| "... in neurological and general medical practice. The high frequency of comorbid conditions and diseases predisposing ..." | ||
| Vol 2, No 2 (2010) | Moderate cognitive disorders as a multidisciplinary problem | Abstract similar documents |
| V. V. Zakharov | ||
| "... , which is outside the normal age values, but does not achieve the degree of dementia. Alzheimer's disease ..." | ||
| Vol 15, No 3 (2023) | Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection | Abstract similar documents |
| E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov | ||
| "... blood of patients with chronic cerebrovascular disease (CCVD) and anamnesis of coronavirus infection ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
| V. A. Golovacheva | ||
| "... findings confirming the presence of cerebrovascular disease, and the neuropsychological study results ..." | ||
| Vol 10, No 1 (2018) | Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment | Abstract similar documents |
| M. P. Platov, O. V. Kosivtsova | ||
| "... walking, and lower mood. At the same time, other diseases that cause these symptoms are not diagnosed ..." | ||
| Vol 6, No 2 (2014) | Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy | Abstract similar documents |
| V.Yu. Lobzin, A.Yu. Emelin, S.V. Vorobyev, I.A. Lupanov | ||
| "... (CI). The pattern of intellectual and amnestic disorders in cerebrovascular disease and methods ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Post-stroke cognitive dysfunctions: A clinical and neuroimaging study | Abstract similar documents |
| Andrei Yuryevich Emelin, V Yu Lobzin, S V Vorobyev, O V Dmitriev, I A Lupanov | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... Alzheimer's disease (AD) is the most common degenerative disease of the brain leading to dementia ..." | ||
| Vol 12, No 5 (2020) | Cognitive impairment, dizziness, and unsteadiness in hypertensive patients | Abstract similar documents |
| L. M. Antonenko, N. V. Vakhnina, D. O. Gromova | ||
| "... and chronic cerebrovascular diseases. The pathogenetic basis of brain damage in hypertension is cerebral ..." | ||
| Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
| A. A. Naumenko, I. S. Preobrazhenskaya | ||
| "... method to basic therapy in patients with Alzheimer's disease (AD) and vascular cognitive impairment (VCI ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... Depression is the most common form of mental illness in patients with cardiovascular diseases (CVD ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke | Abstract similar documents |
| Dina Rustemovna Khasanova, Yu V Zhitkova | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| "... Alzheimer's disease (AD) is the most common neurodegenerative disease and the most common cause ..." | ||
| Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
| Vladimir Ernstovich Medvedev | ||
| "... Psychopathological disorders in patients with cardiovascular diseases (CVD) are treated ..." | ||
| Vol 14, No 5 (2022) | Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society | Abstract similar documents |
| A. V. Sergeev, G. R. Tabeeva, E. G. Filatova, A. V. Amelin, L. R. Akhmadeeva, E. R. Lebedeva, V. V. Osipova, Yu. E. Azimova, N. V. Latysheva, O. B. Doronina, K. V. Skorobogatykh | ||
| "... of migraine using anti-CGRP mAbs and to improve care for patients with various forms of the disease. ..." | ||
| Vol 11, No 2 (2019) | Tobacco smoking dependence in patients with depressive spectrum mental disorders: clinical, pathogenetic, and therapeutic aspects | Abstract similar documents |
| O. I. Speranskaya, S. A. Trushchelev, Z. I. Storozheva | ||
| "... This review considers the clinical and pathogenetic aspects of an association between tobacco ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
| E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
| "... the associations between coronavirus infection and MS and provide data on the features of MS pathogenetic therapy ..." | ||
| Vol 10, No 3 (2018) | Cognitive impairment in patients with migraine: causes, principles of effective prevention and treatment | Abstract similar documents |
| V. A. Golovacheva, K. A. Pozhidaev, A. A. Golovacheva | ||
| "... and neurodegenerative diseases. Other authors report the pathogenetic role of migraine in the development of CI ..." | ||
| Vol 10, No 3 (2018) | Posthypoxic encephalopathy in patients after cardiac surgery: etiological, pathogenetic, and clinical aspects (a literature review) | Abstract PDF (Eng) similar documents |
| T. M. Alekseeva, O. A. Portik, M. P. Topuzova | ||
| "... . Its preoperative risk factors include age, gender, concomitant diseases, education level ..." | ||
| Vol 14, No 2 (2022) | Early-onset Alzheimer's disease | Abstract similar documents |
| A. B. Lokshina, D. A. Grishina, A. V. Obukhova | ||
| "... Alzheimer's disease (AD) is the most common cause of cognitive impairment in adults. There are two ..." | ||
| Vol 4, No 3 (2012) | Current drug treatments for vestibular disorders | Abstract similar documents |
| Maksim Valeryevich Zamergrad | ||
| "... methods of symptomatic and pathogenetic treatment for different diseases of the vestibular system ..." | ||
| Vol 15, No 2 (2023) | Vascular cognitive impairment: issues of diagnosis and treatment | Abstract similar documents |
| A. B. Lokshina, D. A. Grishina, V. V. Zakharov | ||
| "... Vascular brain diseases are one of the leading causes of death and disability in developed ..." | ||
| 1 - 70 of 856 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
